Literature DB >> 21611995

First-trimester screening for large-for-gestational-age infants.

W Plasencia1, E González Dávila, V Tetilla, E Padrón Pérez, J A García Hernández, N L González González.   

Abstract

OBJECTIVES: To examine the relationship between newborn birth weight and first-trimester uterine artery (UtA) pulsatility index (PI), maternal characteristics, serum pregnancy-associated plasma protein-A (PAPP-A), free β-human chorionic gonadotropin (β-hCG) and fetal nuchal translucency (NT) thickness. We also examined the results of screening for large-for-gestational-age (LGA) neonates by an integrated first-trimester approach incorporating these parameters.
METHODS: We evaluated maternal characteristics, fetal NT, PAPP-A, free β-hCG and UtA-PI in 2097 singleton pregnancies at 11 + 0 to 13 + 6 weeks' gestation. Linear models based on quasi Akaike's Information Criterion were used to determine the best predictive model for fetal birth weight. The patient-specific risk of delivering an LGA infant was derived from multiple logistic regression analysis and the performance of screening was determined by receiver-operating characteristics curve analysis.
RESULTS: The best predictive models for fetal birth weight included UtA-PI, PAPP-A, NT, parity, maternal age, smoking status, weight, height and free β-hCG. In pregnancies delivering LGA newborns compared with non-LGA pregnancies, PAPP-A and NT thickness were significantly increased (P = 0.016 and 0.001, respectively) and UtA-PI was significantly decreased (P = 0.011). A combination of maternal factors with PAPP-A, fetal NT and UtA-PI identified 34.4% of LGA newborns for a false-positive rate of 10%.
CONCLUSIONS: This study showed an association between newborn birth weight and maternal factors, and first-trimester PAPP-A, β-hCG, fetal NT and UtA-PI. Together, these factors can be used to identify over a third of pregnancies that will deliver LGA infants.
Copyright © 2012 ISUOG. Published by John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 21611995     DOI: 10.1002/uog.9060

Source DB:  PubMed          Journal:  Ultrasound Obstet Gynecol        ISSN: 0960-7692            Impact factor:   7.299


  6 in total

1.  Macrosomia has its roots in early placental development.

Authors:  N Schwartz; H S Quant; M D Sammel; S Parry
Journal:  Placenta       Date:  2014-07-11       Impact factor: 3.481

2.  Serum pregnancy-associated plasma protein A levels in the first, second and third trimester of pregnancy: relation to newborn anthropometric parameters and maternal tobacco smoking.

Authors:  Magdalena Chełchowska; Joanna Gajewska; Joanna Mazur; Jadwiga Ambroszkiewicz; Tomasz M Maciejewski; Jerzy Leibschang
Journal:  Arch Med Sci       Date:  2016-10-24       Impact factor: 3.318

3.  Comparison of logistic regression with machine learning methods for the prediction of fetal growth abnormalities: a retrospective cohort study.

Authors:  Stefan Kuhle; Bryan Maguire; Hongqun Zhang; David Hamilton; Alexander C Allen; K S Joseph; Victoria M Allen
Journal:  BMC Pregnancy Childbirth       Date:  2018-08-15       Impact factor: 3.007

4.  Fetal nuchal translucency: is there an association with birthweight and neonatal wellbeing?

Authors:  Ziya Kalem; Aşkı Ellibeş Kaya; Batuhan Bakırarar; Müberra Namlı Kalem
Journal:  Turk J Obstet Gynecol       Date:  2019-03-27

5.  Early Mid-pregnancy Blood-Based Proteins as Possible Biomarkers of Increased Infant Birth Size in Sex-Stratified Analyses.

Authors:  Emelie Lindberger; Fredrik Ahlsson; Katja Junus; Theodora Kunovac Kallak; Susanne Lager; Paliz Nordlöf Callbo; Anna-Karin Wikström; Inger Sundström Poromaa
Journal:  Reprod Sci       Date:  2022-09-30       Impact factor: 2.924

6.  External validation and clinical usefulness of first-trimester prediction models for small- and large-for-gestational-age infants: a prospective cohort study.

Authors:  Lje Meertens; Ljm Smits; Smj van Kuijk; R Aardenburg; Ima van Dooren; J Langenveld; I M Zwaan; Mea Spaanderman; Hcj Scheepers
Journal:  BJOG       Date:  2019-01-17       Impact factor: 6.531

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.